Low-grade Serous Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Low-grade Serous Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients [Phase 2]
Phase 2 clinical trial evaluating Avutometinib plus Defactinib in Japanese patients with recurrent low-grade serous ovarian cancer; the stud…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone [Phase 2]
Phase 2 study of Onapristone ER alone or with Anastrozole in progesterone-responsive gynecologic cancers has completed. Results were posted …
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial) [Phase 3]
A Phase 3 trial (LEPRE) is evaluating letrozole for estrogen/progesterone receptor-positive low-grade serous epithelial ovarian cancer and i…
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer [Phase 3]
Phase 3 trial comparing MEK162 to physician's choice chemotherapy in low-grade serous ovarian/fallopian tube/peritoneal cancer was terminate…